Skip Navigation


European Heart Journal Advance Access originally published online on April 7, 2008
European Heart Journal 2008 29(9):1084-1085; doi:10.1093/eurheartj/ehn051
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/9/1084    most recent
ehn051v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Van Wagoner, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Wagoner, D. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Evaluating the impact of atrial dilatation on atrial calcium cycling

David R. Van Wagoner*

Department of Molecular Cardiology, NE-61, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA

* Corresponding author. Email: vanwagd{at}ccf.org

This editorial refers to ‘Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation’{dagger} by S. Dinanian et al., on page 1190

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

With increased longevity, the prevalence of ageing-related diseases is increasing. Atrial fibrillation (AF) is one of the age-related conditions that is approaching epidemic proportions. AF is an important cause of cardioembolic stroke, and the primary cause of cardioembolic stroke in the elderly population. Thrombus formation is in part attributed to the greatly impaired atrial contractility during AF. As in the ventricle, atrial contractility is dependent on the excitation–contraction coupling process in which calcium influx promotes release of calcium from intracellular stores; it is the rise of intracellular calcium that initiates cross-bridge cycling and muscle contraction. Muscle relaxation during diastole occurs upon resequestration or extrusion of cytosolic calcium. Regulation of calcium cycling is a critical determinant of atrial contractility, and calcium influx via L-type calcium channels (ICa,L) during each heart beat is a critical determinant of calcium cycling. From a combination of electrophysiological studies in experimental animal models,1,2 it is now widely appreciated that calcium influx is dramatically (~70%) attenuated following the onset of AF. Comparisons of calcium current density in myocytes isolated from patients in either sinus rhythm or AF at the time of cardiac surgery have revealed a nearly identical downregulation that has been primarily attributed to the presence of AF.3–5

Atrial enlargement (dilatation), especially of the left atrium, has long been identified as a predictor of increased risk of atrial fibrillation, stroke, and mortality.6,7 In 1994, Le Grand and colleagues were the first to characterize the cellular electrophysiology of patients with dilated atria.8 Their study documented a significant downregulation in ICa,L and the transient outward potassium current (ITO), suggesting that dilation is a sufficient stimulus to initiate the electrical remodelling process that is also characteristic of myocytes from patients with AF. It is probably not coincidental that AF is frequently characterized by atrial dilatation and myocyte hypertrophy, and that dilatation has a significant impact on the persistence of AF.9

In an extension of the landmark studies of Le Grand et al.,8 Dinanian et al.10 report on calcium current measurements made from right atrial myocytes isolated from an impressively large series of 86 cardiac surgery patients, with varying indications for cardiac surgery. Here the authors report that mitral valve disease and atrial dilatation independent of AF are accompanied by reductions in ICa,L that are as substantial as those changes associated with AF. Further, they report that a low ejecion fraction (EF) has a similar effect on those patients presenting for surgery in sinus rhythm (with no reported history of AF). The lowest ICa,L values were recorded from myocytes that were most hypertrophied.

It is unclear (and was not studied) whether the reduction of ICa,L that is reported was the result of transcriptional regulation or post-translational modification(s) of channel activity. In an expression array study, it has been reported that there is substantial overlap in the profile of changes in mRNA expression in tissues from patients with valvular disease vs. those with AF and valvular disease.11 A comparison of calcium channel expression among patients in AF vs. matched patients in sinus rhythm using western blot and dihydropyridine binding assays suggests that transcriptional regulation of calcium channels was not prominent, and thus not a likely explanation for the observed current downregulation in AF.

Experiments using isoproterenol to stimulate β-adrenergic receptors revealed that, as is characteristic of myocytes from patients in AF,5,12 atrial myocytes with the lowest baseline ICa,L had the greatest response to stimulation by isoproterenol, suggesting that the channels are less active due, at least in part, to a relative state of dephosphorylation. Increased phosphodiesterase activity in response to increased atrial natriuretic peptide levels and activation of guanylate cyclase activity in the patients with dilated atria is one of the mechanisms proposed to underlie the observed reduction in ICa,L.

Another interesting observation in this study is that of a lower mean density of ICa,L in myocytes isolated from men10. Recent studies in mice have shown that L-type calcium channels can be modified by S-nitrosylation,13 and that gender differences in the abundance of nitric oxide may contribute to gender-specific regulation of channel activity. We have recently shown that S-nitrosylation of the calcium channel occurs in human AF, and that nitrosylation is increased under conditions in which atrial glutathione levels are depleted (oxidant stress).14 Experimental glutathione depletion leads to impaired atrial contractility.14 It is interesting that increased wall stress increases oxidant production, in part due to increased NADPH oxidase activity.15 Thus, increased oxidant production might also contribute to the decrement in ICa,L in the myocytes from patients with dilated atria.

NADPH oxidase activity is increased in human AF,16 and atrial NADPH oxidase activity at the time of surgery has recently been associated with the occurrence of AF following cardiac surgery.17 In this report,10 Dinanian et al. note in the Discussion that no relationship could be detected between the calcium current density in myocytes obtained at the time of surgery and the occurrence of AF during the post-operative period.

The observation of Dinanian et al., showing a downregulation of atrial calcium currents in myocytes isolated from patients with dilated atria and impaired cardiac function, is likely to be consistent with the increased risk of AF and stroke in these patients. However, the downregulation may protect the atria that are already haemodynamically challenged from the additional metabolic burden associated with increased contractile activity. Thus, efforts to improve the systemic haemodynamics (via control of heart rate, hypertension, cardiac perfusion, etc.) may have greater therapeutic benefit than efforts targeted at increasing atrial calcium influx directly.

Conflict of interest: none declared.

Acknowledgements

Dr Van Wagoner is supported by the Atrial Fibrillation Innovation Center, an Ohio Wright Center Initiative, and by the Fondation Leducq European-North American Atrial Fibrillation Research Alliance.

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

{dagger} doi:10.1093/eurheartj/ehn140 Back

References

  1. Bosch RF, Scherer CR, Rüb N, Wohrl S, Steinmeyer K, Haase H, Busch AE, Seipel L, Kühlkamp V. Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces ICa,L and Ito in rapid atrial pacing in rabbits. J Am Coll Cardiol (2003) 41:858–869.[Abstract/Free Full Text]
  2. Yue L, Feng J, Gaspo R, Li G-R, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res (1997) 81:512–525.[Abstract/Free Full Text]
  3. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kühlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res (1999) 44:121–131.[Abstract/Free Full Text]
  4. Skasa M, Jungling E, Picht E, Schondube F, Luckhoff A. L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol (2001) 96:151–159.[CrossRef][Web of Science][Medline]
  5. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. L-type Ca2+ currents and human atrial fibrillation. Circ Res (1999) 85:428–436.[Abstract/Free Full Text]
  6. Bangalore S, Yao SS, Chaudhry FA. Role of left atrial size in risk stratification and prognosis of patients undergoing stress echocardiography. J Am Coll Cardiol (2007) 50:1254–1262.[Abstract/Free Full Text]
  7. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 92:835–841.[Abstract/Free Full Text]
  8. Le Grand B, Hatem S, Deroubaix E, Couétil J-P, Coraboeuf E. Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res (1994) 28:548–556.[Web of Science][Medline]
  9. Kojodjojo P, Peters NS, Davies DW, Kanagaratnam P. Characterization of the electroanatomical substrate in human atrial fibrillation: the relationship between changes in atrial volume, refractoriness, wavefront propagation velocities, and AF burden. J Cardiovasc Electrophysiol (2007) 18:269–275.[CrossRef][Web of Science][Medline]
  10. Dinanian S, Boixel C, Juin C, Hulot J-S, Coulombe A, Rücker-Martin C, Bonnet N, Le Grand B, Slama M, Mercadier J-J, Hatem SN. Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation. Eur Heart J (2008) 29:1190–1197. First published on April 7, 2008. doi:10.1093/eurheartj/ehn140.[Abstract/Free Full Text]
  11. Lamirault G, Gaborit N, Le Meur N, Chevalier C, Lande G, Demolombe S, Escande D, Nattel S, Léger JJ, Steenman M. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J Mol Cell Cardiol (2006) 40:173–184.[CrossRef][Web of Science][Medline]
  12. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation (2004) 110:2651–2657.[Abstract/Free Full Text]
  13. Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res (2006) 98:403–411.[Abstract/Free Full Text]
  14. Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR. Atrial glutathione content, calcium current and contractility. J Biol Chem (2007) 282:28063–28073.[Abstract/Free Full Text]
  15. Zhou C, Ziegler C, Birder LA, Stewart AF, Levitan ES. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ Res (2006) 98:1040–1047.[Abstract/Free Full Text]
  16. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res (2005) 97:629–636.[Abstract/Free Full Text]
  17. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol (2008) 51:68–74.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation
Sylvie Dinanian, Christophe Boixel, Christophe Juin, Jean-Sébastien Hulot, Alain Coulombe, Catherine Rücker-Martin, Nicolas Bonnet, Bruno Le Grand, Michel Slama, Jean-Jacques Mercadier, and Stéphane N. Hatem
EHJ 2008 29: 1190-1197. [Abstract] [FREE Full Text]  




This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/9/1084    most recent
ehn051v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Van Wagoner, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Wagoner, D. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?